{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:40:08Z","timestamp":1793295608039,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005088","name":"Beijing Municipal Health Commission","doi-asserted-by":"publisher","award":["BRWEP2024W054070100"],"award-info":[{"award-number":["BRWEP2024W054070100"]}],"id":[{"id":"10.13039\/501100005088","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["2025SF067"],"award-info":[{"award-number":["2025SF067"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370773"],"award-info":[{"award-number":["82370773"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["2024IR16"],"award-info":[{"award-number":["2024IR16"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.euros.2026.09.002","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:36:11Z","timestamp":1790282171000},"page":"26-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PRECISE Assessment of Sequential Biparametric MRI and Clinically Significant Prostate Cancer in Biopsy-naive Men: A Retrospective Cohort Study"],"prefix":"10.1016","volume":"93","author":[{"given":"Yuxuan","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjian","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2026.09.002_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euros.2026.09.002_b0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.09.002_b0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.urolonc.2016.03.001","article-title":"Prostate cancer risk stratification with magnetic resonance imaging","volume":"34","author":"Felker","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euros.2026.09.002_b0020","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.euf.2021.11.005","article-title":"Risk stratification and artificial intelligence in early magnetic resonance imaging-based detection of prostate cancer","volume":"8","author":"de Rooij","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euros.2026.09.002_b0025","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.09.002_b0030","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/JU.0000000000001306","article-title":"Risk stratification of prostate cancer according to PI-RADS\u00ae version 2 categories: meta-analysis for prospective studies","volume":"204","author":"Park","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2026.09.002_b0035","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.annonc.2025.12.009","article-title":"Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"37","author":"Walz","year":"2026","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euros.2026.09.002_b0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.euo.2023.01.003","article-title":"Best current practice and research priorities in active surveillance for prostate cancer-a report of a movember international consensus meeting","volume":"6","author":"Moore","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euros.2026.09.002_b0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.eururo.2021.12.007","article-title":"Systematic review of active surveillance for clinically localised prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy","volume":"81","author":"Willemse","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.09.002_b0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.euros.2023.08.006","article-title":"Clinical application of the prostate cancer radiological estimation of change in sequential evaluation score for reporting magnetic resonance imaging in men on active surveillance for prostate cancer","volume":"56","author":"Aerts","year":"2023","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euros.2026.09.002_b0055","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.eururo.2024.03.014","article-title":"PRECISE version 2: updated recommendations for reporting prostate magnetic resonance imaging in patients on active surveillance for prostate cancer","volume":"86","author":"Englman","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.09.002_b0060","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2214\/AJR.23.29518","article-title":"The PRECISE recommendations for prostate MRI in patients on active surveillance for prostate cancer: a critical review","volume":"221","author":"Sanmugalingam","year":"2023","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.euros.2026.09.002_b0065","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/MOU.0000000000000397","article-title":"Role of MRI in low-risk prostate cancer: finding the wolf in sheep\u2019s clothing or the sheep in wolf\u2019s clothing?","volume":"27","author":"Schoots","year":"2017","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.euros.2026.09.002_b0070","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.urology.2023.07.019","article-title":"Prostate cancer radiological estimation of change in sequential evaluation (PRECISE) magnetic resonance imaging scoring to predict clinical outcomes in active surveillance for grade group 1 prostate cancer","volume":"180","author":"Bhanji","year":"2023","journal-title":"Urology"},{"key":"10.1016\/j.euros.2026.09.002_b0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jamaoncol.2024.5497","article-title":"Oncological safety of MRI-informed biopsy decision-making in men with suspected prostate cancer","volume":"11","author":"Hamm","year":"2025","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euros.2026.09.002_b0080","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/jama.2025.13722","article-title":"Biparametric vs multiparametric MRI for prostate cancer diagnosis: the PRIME diagnostic clinical trial","volume":"334","author":"Ng","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.euros.2026.09.002_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.111186","article-title":"Bi-parametric prostate MRI with a recall system for contrast enhanced imaging: improving accessibility while maintaining quality","volume":"169","author":"Rehman","year":"2023","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.euros.2026.09.002_b0090","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euros.2026.09.002_b0095","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.juro.2017.03.130","article-title":"The value of PSA density in combination with PI-RADS\u2122 for the accuracy of prostate cancer prediction","volume":"198","author":"Distler","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2026.09.002_b0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/bju.15277","article-title":"Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation","volume":"127","author":"Schoots","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2026.09.002_b0105","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1038\/s41598-024-57337-y","article-title":"PI-RADS v2.1 and PSAD for the prediction of clinically significant prostate cancer among patients with PSA levels of 4\u201310\u00a0ng\/ml","volume":"14","author":"Wen","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.euros.2026.09.002_b0110","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1007\/s00261-022-03592-4","article-title":"Diagnostic value of combining PI-RADS v2.1 with PSAD in clinically significant prostate cancer","volume":"47","author":"Wei","year":"2022","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.euros.2026.09.002_b0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41585-020-00400-w","article-title":"Genomic and phenotypic heterogeneity in prostate cancer","volume":"18","author":"Haffner","year":"2021","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euros.2026.09.002_b0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2214\/AJR.20.24370","article-title":"Prospective PI-RADS v2.1 atypical benign prostatic hyperplasia nodules with marked restricted diffusion: detection of clinically significant prostate cancer on multiparametric MRI","volume":"217","author":"Costa","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.euros.2026.09.002_b0125","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1007\/s00330-017-4775-2","article-title":"Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI","volume":"27","author":"Iyama","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euros.2026.09.002_b0130","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.ejrad.2016.04.014","article-title":"Differentiation of prostatitis and prostate cancer using the Prostate Imaging-Reporting and Data System (PI-RADS)","volume":"85","author":"Meier-Schroers","year":"2016","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.euros.2026.09.002_b0135","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1148\/radiol.12111683","article-title":"Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T","volume":"267","author":"Nagel","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.euros.2026.09.002_b0140","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1007\/s00330-020-07336-0","article-title":"MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance","volume":"31","author":"Caglic","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euros.2026.09.002_b0145","first-page":"398","article-title":"MRI-derived PRECISE score for predicting pathologically-confirmed progression in prostate cancer patients on active surveillance","volume":"77","author":"Carletti","year":"2024","journal-title":"Cent Eur J Urol"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326016344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326016344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:29:36Z","timestamp":1793294976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168326016344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":29,"alternative-id":["S2666168326016344"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2026.09.002","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PRECISE Assessment of Sequential Biparametric MRI and Clinically Significant Prostate Cancer in Biopsy-naive Men: A Retrospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2026.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}